ERIKA MUNNS: Open Payments
NPI 1396411096 · WASHINGTON TERRACE, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$242 in 13 payments from 7 companies in 2025. Trend: 2023 $102 · 2024 $240 · 2025 $242
Food & beverage: $242
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $72 |
| Novartis Pharmaceuticals Corporation | 2 | $47 |
| Regeneron Healthcare Solutions, Inc. | 2 | $34 |
| Organon LLC | 2 | $31 |
| Almirall LLC | 1 | $23 |
| Arcutis Biotherapeutics, Inc. | 1 | $18 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $16 |
Products named: COSENTYX, RINVOQ, LIBTAYO, SKYRIZI, Seysara, Zoryve, Winlevi, NEXPLANON.
Industry payments across UT — which companies pay providers there.
